Development

BioMarin reports five-year Pompe disease results

development2026-10-03biotech

Claim

The newsletter reports BioMarin’s Pompe therapy maintaining patient stability over five years.

Reported metric: five years

Reporting date: 2026-10-03 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Welcome to October 3, 2026 (theinnermostloop.substack.com)
Source linked by the October 3 issue (www.cnbc.com)

Indexed from Dr. Alex Wissner-Gross’s October 3, 2026 newsletter. Linked-source claims have not been independently verified.

Knowledge graphopen in browser →

Reported in

Welcome to October 3, 2026

Actor

BioMarin

Referenced by

Welcome to October 3, 2026

Cite or correct this record

Citation formatCitation text

BioMarin reports five-year Pompe disease results
Innermost Loop KB — secondary record
Reporting date: 2026-10-03
KB permalink: https://nicholsn.github.io/innermost-loop-kb/developments/2026-10-03-pompe-followup
Claim: The newsletter reports BioMarin’s Pompe therapy maintaining patient stability over five years.
Attributed sources:
- Welcome to October 3, 2026 — https://theinnermostloop.substack.com/p/welcome-to-october-3-2026
- Source linked by the October 3 issue — https://www.cnbc.com/2026/10/02/biomarin-reports-five-year-pompe-disease-data-.html
This citation does not imply independent verification of linked-source claims.

Suggest a correction — opens a GitHub draft for you to review and submit.